These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 8510932)
1. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1. Catling AD; Wyke JA; Frame MC Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932 [TBL] [Abstract][Full Text] [Related]
2. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein. Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299 [TBL] [Abstract][Full Text] [Related]
3. Functions of the v-Src protein tyrosine kinase. Fincham V; Frame M; Haefner B; Unlu M; Wyke A; Wyke J Cell Biol Int; 1994 May; 18(5):337-44. PubMed ID: 8049678 [TBL] [Abstract][Full Text] [Related]
4. Mitogenesis induced by pp60v-src is not accompanied by increased expression of immediate early response genes. Welham MJ; Wyke JA; Lang A; Wyke AW Oncogene; 1990 Feb; 5(2):161-9. PubMed ID: 2108404 [TBL] [Abstract][Full Text] [Related]
5. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences. Hadman M; Loo M; Bos TJ Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1. Murakami M; Sonobe MH; Ui M; Kabuyama Y; Watanabe H; Wada T; Handa H; Iba H Oncogene; 1997 May; 14(20):2435-44. PubMed ID: 9188858 [TBL] [Abstract][Full Text] [Related]
7. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction. Kilbey A; Black EJ; Unlu M; Gillespie DA Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782 [TBL] [Abstract][Full Text] [Related]
8. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation. Su ZZ; Yemul S; Stein CA; Fisher PB Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104 [TBL] [Abstract][Full Text] [Related]
9. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts. Lallemand D; Spyrou G; Yaniv M; Pfarr CM Oncogene; 1997 Feb; 14(7):819-30. PubMed ID: 9047389 [TBL] [Abstract][Full Text] [Related]
10. fra-2 promoter can respond to serum-stimulation through AP-1 complexes. Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446 [TBL] [Abstract][Full Text] [Related]
11. v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts. Fincham VJ; Wyke JA; Frame MC Oncogene; 1995 Jun; 10(11):2247-52. PubMed ID: 7784071 [TBL] [Abstract][Full Text] [Related]
12. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging. Whisler RL; Chen M; Beiqing L; Carle KW Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Smeal T; Binetruy B; Mercola DA; Birrer M; Karin M Nature; 1991 Dec; 354(6353):494-6. PubMed ID: 1749429 [TBL] [Abstract][Full Text] [Related]
14. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737 [TBL] [Abstract][Full Text] [Related]
15. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation. Hartl M; Bister K Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996 [TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells. Maroney AC; Qureshi SA; Foster DA; Brugge JS Oncogene; 1992 Jun; 7(6):1207-14. PubMed ID: 1375718 [TBL] [Abstract][Full Text] [Related]
17. Intracellular targeting of pp60src expression: localization of v-src to adhesion plaques is sufficient to transform chicken embryo fibroblasts. Liebl EC; Martin GS Oncogene; 1992 Dec; 7(12):2417-28. PubMed ID: 1334249 [TBL] [Abstract][Full Text] [Related]
18. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels. Gruebele A; Zawaski K; Kaplan D; Novak RF Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185 [TBL] [Abstract][Full Text] [Related]
19. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes. Tay DL; Hoffbrand AV; Wickremasinghe GR Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353 [TBL] [Abstract][Full Text] [Related]
20. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts. Basso J; Briggs J; Findlay C; Bos T Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]